Search for: "Janssen Biotech Inc"
Results 1 - 20
of 75
Sorted by Relevance
|
Sort by Date
10 Jul 2014, 9:59 pm
("AbbVie") and Janssen Biotech, Inc. and Centocor Biologics, LLC ("Centocor"). [read post]
29 Jan 2018, 9:59 pm
Janssen Biotech, Inc. and New York University ("Janssen"), co-assignees of the '471 patent, argued on appeal that obviousness-type double patenting was not applicable because the safe-harbor provision of 35 U.S.C. [read post]
15 May 2017, 9:50 pm
Patent and Trademark Office has now filed its response brief in In re: Janssen Biotech, Inc., New York University, No. 2017-1257 (Fed. [read post]
14 Apr 2016, 9:27 pm
Food and Drug Administration approved Celltrion's application to market Inflectra, a biosimilar to Janssen Biotech Inc.'s REMICADE (infliximab) anti-TNF-α antibody. [read post]
1 Nov 2015, 9:57 pm
Janssen Biotech Inc. et al. v. [read post]
28 Jun 2016, 9:08 pm
Janssen Biotech, Inc. v. [read post]
23 May 2012, 9:22 pm
Searle, LLC • Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
9 Mar 2015, 9:59 pm
Janssen Biotech, Inc. et al. v. [read post]
31 Jan 2019, 1:15 pm
Janssen Biotech, Inc., No. 16-221 (LPS) (Dkt. 471) (Jan. 25, 2019), invalidated broad antibody patents for not being sufficiently enabled, as well as coming near to invalidating the same patents for lacking written description. [read post]
27 Nov 2022, 8:41 pm
The case arose as ANDA litigation between Pharmacyclics LLC and Janssen Biotech, Inc., whose patents for the compound ibrutinib (an inhibitor of Burton's tyrosine kinase (BTK) and the basis for their Imbruvica... [read post]
20 Apr 2014, 9:11 pm
• Defendant: Janssen Biotech, Inc. [read post]
29 Dec 2013, 9:15 pm
Janssen Pharmaceuticals Inc. et al. v. [read post]
10 Jul 2014, 10:00 pm
Janssen Biotech, Inc. [read post]
18 May 2014, 8:42 pm
Mylan Pharmaceuticals Inc. et al. 1:14-cv-00594; filed May 12, 2014 in the District Court of Delaware • Plaintiffs: Alza Corp.; Janssen Pharmaceuticals Inc. [read post]
17 Jun 2012, 9:55 pm
Searle, LLC • Defendants: Hetero Drugs, Ltd., Unit III; Invagen Pharmaceuticals, Inc. [read post]
14 Jun 2015, 8:59 pm
Janssen Pharmaceuticals Inc. v. [read post]
14 Nov 2013, 5:00 am
Sister companies include Janssen Biotech and Janssen Theraputices. [read post]
19 Oct 2016, 9:58 pm
By Andrew Williams -- On April 5, 2016, the FDA approved Celltrion's application to market a biosimilar to Janssen Biotech Inc.'s REMICADE® (infliximab) anti-TNF-α antibody (see "FDA Approves Inflectra - Celltrion's REMICADE® Biosimilar"). [read post]
23 May 2011, 9:59 pm
Impax Laboratories, Inc. et al. 1:11-cv-00395; filed May 5, 2011 in the District Court of Delaware • Plaintiffs: Alza Corp.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
18 Aug 2008, 3:48 am
Janssen Pharmaceutica N.V. et al. v. [read post]
